🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the long-term safety and tolerability of sibeprenlimab in subje...
Status
Enrolling By Invitation
Location
Clinical Research Site #336
Start Date
2022-04-05
Trial ID
NCT05248659
Treatments Being Tested
To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutane...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - Site #336
Start Date
2022-03-15
Trial ID
NCT05248646
Treatments Being Tested
This Phase 3, open-label study will evaluate the efficacy, safety, tolerabi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07770815
Treatments Being Tested
This is a phase 2 study to evaluate the effects of sibeprenlimab 400 mg adm...
Status
Active Not Recruiting
Location
Medvin Clinical Research - Riverside
Start Date
2025-04-23
Trial ID
NCT06928142
Treatments Being Tested
This is a phase 2b open-label trial to characterize histopathological bioma...
Status
Recruiting
Location
Clinical Research Site 330
Start Date
2024-11-19
Trial ID
NCT06740526
Treatments Being Tested
A Trial to Assess the Pharmacokinetics, Safety and Tolerability, and Pharma...
Status
Completed
Location
West China Hospital of Sichuan University
Start Date
2022-10-18
Trial ID
NCT07105124
Treatments Being Tested